GRM5 and Alzheimer disease: Thus, inhibiting mGluR5 can alleviate the neurotoxic burden of astrocytes in AD brain that may be a contributor to the disease-modifying outcomes reported in AD mice following mGluR5 silencing [28, 30, 72].